In addition, 25% of GH-producing pituitary tumors showed no expression of SOX9 while 20 and 55% of tumors revealed a weak and moderate SOX9 protein expression (Score 1+, Score 2+), respectively (Table 6). Here, SOX9 is linked to pituitary tumor.